We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Insys To Pay $150M To End DOJ Scrutiny Of Opioid-Rx Bribes

Law360 (August 8, 2018, 3:17 PM EDT) -- Opioid manufacturer Insys Therapeutics Inc. has agreed to pay at least $150 million for the U.S. Department of Justice to drop its criminal investigation and civil claims that the company bribed doctors to prescribe its under-the-tongue fentanyl spray, the company announced Wednesday.

Insys' former executives are facing criminal charges separate from the probe of the company. Insys founder John Kapoor, left, is shown leaving Boston federal court in November after pleading not guilty to conspiracy and bribery charges. (Alison Noon/Law360)

The Arizona-based drugmaker, whose former executives...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.